欧盟药品监管机构推荐卫材-百健的阿尔茨海默氏症药物

Reuters
15 Nov 2024

((自动化翻译由路透提供,请见免责声明 ))

路透11月14日 - 欧盟药品监管机构周四表示,建议批准卫材 和百健 的Leqembi用于早期阿尔茨海默病患者的治疗,几个月前该机构首次拒绝了这种治疗方法。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10